Attached files

file filename
8-K - 8-K - XILINX INCa8-kpressrelease12115.htm


Exhibit 99.1
Investor Relations Contact:                            
Lori Owen
Xilinx, Inc.
(408) 879-6911
ir@xilinx.com




Xilinx announces Q3 FISCAL 2015 results; EPS $0.62


SAN JOSE, CA, January 21, 2015-- Xilinx, Inc. (Nasdaq: XLNX) today announced third quarter fiscal 2015 sales of $594 million, down 2% from the prior quarter and up 1% from the same quarter of the prior fiscal year. Third quarter fiscal 2015 net income was $168 million or $0.62 per share, including a $0.02 per diluted share benefit primarily related to the reinstatement of the R&D tax credit.
The Xilinx Board of Directors announced a quarterly cash dividend of $0.29 per outstanding share of common stock, payable on February 25, 2015 to all stockholders of record at the close of business on February 4, 2015.
Additional third quarter comparisons are represented in the charts below:



GAAP Results
(In millions, except EPS)
                     
 
 
 
 
 
  Growth Rates
 
Q3
FY 2015
Q2
FY 2015
Q3
FY 2014
 

Q-T-Q

Y-T-Y
Net revenues
$593.5
$604.3
$568.8
 
-2%
1%
Operating income
$190.0
$200.0
$202.7
 
-5%
-6%
Net income
$168.5
$171.5
$175.9
 
-2%
-4%
Diluted earnings per share
$0.62
$0.62
$0.61
 
0%
2%

“Solid profitability during the quarter was tempered by disappointing sales from broadcast and communications end markets,” said Moshe Gavrielov, Xilinx President and Chief Executive Officer. “However, I am pleased with the renewed growth of our 28nm product family, which increased nearly 20% sequentially. I expect this product family to continue to post healthy growth in 2015 driven by a broad base of applications.”











Net Revenues by Geography:     
 
Percentages
 
Growth Rates
 
Q3
FY 2015
Q2
FY 2015
Q3
FY 2014
 

Q-T-Q

Y-T-Y
North America
34%
32%
29%
 
4%
18%
Asia Pacific
29%
37%
40%
 
3%
-2%
Europe
17%
21%
22%
 
-18%
-16%
Japan
10%
10%
9%
 
-4%
2%

Net Revenues by End Market:               
 
Percentages
 
Growth Rates
 
Q3
FY 2015
Q2
FY 2015
Q3
FY 2014
 

Q-T-Q

Y-T-Y
Communications & Data Center
41%
41%
44%
 
-3%
-7%
Industrial, Aerospace & Defense
43%
41%
37%
 
4%
18%
Broadcast, Consumer & Automotive
14%
15%
16%
 
-6%
-9%
Other
2%
3%
3%
 
-41%
-39%

Net Revenues by Product:                           
 
Percentages
 
Growth Rates
       
Q3
FY 2015
Q2
FY 2015
Q3
FY 2014
 

Q-T-Q

Y-T-Y
New
43%
43%
38%
 
-1%
14%
Mainstream
29%
31%
33%
 
-8%
-10%
Base
25%
23%
26%
 
4%
-3%
Support
3%
3%
3%
 
-2%
-1%

Products are classified as follows:

New products: Virtex® UltraScale™, Kintex® UltraScale, Virtex-7, Kintex‐7, Artix®-7, Zynq®-7000, Virtex‐6, Spartan®‐6 products
Mainstream products: Virtex‐5, Spartan‐3 and CoolRunner™‐II products
Base products: Virtex‐4, Virtex‐II, Virtex‐E, Virtex, Spartan-II, Spartan, CoolRunner and XC9500 products
Support products: Configuration solutions, HardWire, Software & Support/Services

Key Statistics:
(Dollars in millions)
 
Q3
FY 2015
Q2
FY 2015
Q3
FY 2014
Annual Return on Equity (%)*
25
25
20
 
 
 
 
Operating Cash Flow
$291
$204
$216
 
 
 
 
Depreciation Expense
$14
$14
$14
 
 
 
 
Capital Expenditures
$6
$8
$11
 
 
 
 
Combined Inventory Days
134
153
114
 
 
 
 
Revenue Turns (%)
44
48
52

*Return on equity calculation: Annualized net income/average stockholders’ equity







Highlights - December Quarter Fiscal 2015


Xilinx 28nm products exceeded $150 million in sales for the quarter, up nearly 20% sequentially and up over 50% from the same quarter a year ago. Sales from all product family members increased sequentially and were driven by a broad base of applications.

Xilinx recently introduced its Kintex UltraScale devices, which are the industry’s first 20nm FPGAs to move into volume production. Customers can benefit from an estimated one-year time to market advantage relative to its competition. At 20nm, Xilinx also announced that it is now shipping the industry’s largest FPGA, which delivers over 4X the capacity of competitive devices and extends its high-end leadership.

Xilinx announced the SDAccel™ development environment for OpenCL™, C, and C++, enabling up to 25X better performance/watt for data center application acceleration leveraging FPGAs. SDAccel, the newest member of the SDx™ family, combines the industry's first architecturally optimizing compiler supporting any combination of OpenCL, C, and C++ kernels, along with libraries, development boards, and the first complete CPU/GPU-like development and run-time experience for FPGAs.

In November, Xilinx Board of Directors granted an authorization for the Company to repurchase up to $800 million of its common stock. Since fiscal 2010, the Company has repurchased over 50 million shares for approximately $1.8 billion. 

Business Outlook - March Quarter Fiscal 2015
Sales are expected to be down 2% to down 6% sequentially.
Gross margin is expected to be approximately 68% to 69%.
Operating expenses are expected to be approximately $227 million including $2.5 million of amortization of acquisition-related intangibles.
Other income and expenses are expected to be a net expense of approximately $7 million.
Fully diluted share count is expected to be approximately 270 million.
March quarter tax rate is expected to be approximately 13%.

Conference Call
A conference call will be held today at 2:00 p.m. Pacific Time to discuss the December quarter financial results and management's outlook for the March quarter. The webcast and subsequent replay will be available in the investor relations section of the Company's web site at www.investor.xilinx.com. A telephonic replay of the call may be accessed later in the day by calling (855) 859-2056 and referencing confirmation code 50649087. The telephonic replay will be available for two weeks following the live call.













This release contains forward-looking statements and projections. Forward-looking statements and projections can often be identified by the use of forward-looking words such as “expect,” “believe,” “may,” “will,” “could,” “anticipate,” “estimate,” “continue,” “plan,” “intend,” “project” or other similar expressions. Statements that refer to or are based on projections, uncertain events or assumptions also identify forward-looking statements. Such forward looking statements include, but are not limited to, statements related to the semiconductor market, the growth and acceptance of our products, expected revenue growth, the demand and growth in the markets we serve, opportunity for expansion into new markets, and our expectations regarding our business outlook for the March quarter of fiscal 2015. Undue reliance should not be placed on such forward-looking statements and projections, which speak only as of the date they are made. We undertake no obligation to update such forward-looking statements. Actual events and results may differ materially from those in the forward-looking statements and are subject to risks and uncertainties including customer acceptance of our new products, current global economic conditions, the health of our customers and the end markets in which they participate, our ability to forecast end customer demand, a high dependence on turns business, more customer volume discounts than expected, greater product mix changes than anticipated, fluctuations in manufacturing yields, our ability to deliver product in a timely manner, our ability to successfully manage production at multiple foundries, variability in wafer pricing, costs and liabilities associated with current and future litigation, and other risk factors listed in our most recent Forms 10-Q and 10-K.


About Xilinx

Xilinx develops All Programmable technologies and devices, beyond hardware to software, digital to analog, and single to multiple die in 3D ICs.  These industry leading devices are coupled with a next-generation design environment and IP to serve a broad range of customer needs, from programmable logic to programmable systems integration.  For more information, visit www.xilinx.com.

#1503F
Xilinx, the Xilinx logo, Artix, ISE, Kintex, Spartan, Virtex, Zynq, Vivado, and other designated brands included herein are trademarks of Xilinx in the United States and other countries. All other trademarks are the property of their respective owners.
XLNX-F






XILINX, INC.





 
 
 
 
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
 
 
 
 
(Unaudited)





 
 
 
 
(In thousands, except per share amounts)



 
 
 
 

Three Months Ended
 
Nine Months Ended

December 27, 2014

September 27, 2014

December 28, 2013
 
December 27, 2014

December 28, 2013
Net revenues
$
593,549


$
604,262


$
586,816

 
$
1,810,445


$
1,764,708

Cost of revenues
179,638


169,617


180,792

 
538,445


543,308

Gross margin
413,911


434,645


406,024

 
1,272,000


1,221,400

Operating expenses:





 
 
 
 
Research and development
133,455


138,335


128,092

 
393,803


364,635

Selling, general and administrative
88,076


93,883


91,794

 
274,472


280,520

Amortization of acquisition-related intangibles
2,371


2,378


2,589

 
7,167


7,425

Litigation and contingencies




(19,190
)
 


9,410

Total operating expenses
223,902


234,596


203,285

 
675,442


661,990










 
 
 
 
Operating income
190,009


200,049


202,739

 
596,558


559,410

Interest and other expense, net
4,007


5,731


4,807

 
15,960


25,734

Income before income taxes
186,002


194,318


197,932

 
580,598


533,676

Provision for income taxes
17,536


22,802


22,055

 
67,005


59,315

Net income
$
168,466


$
171,516


$
175,877

 
$
513,593


$
474,361

Net income per common share:





 
 
 
 
Basic
$
0.64


$
0.64


$
0.66

 
$
1.93


$
1.78

Diluted
$
0.62


$
0.62


$
0.63

 
$
1.85


$
1.66

Cash dividends per common share
$
0.29


$
0.29


$
0.25

 
$
0.58


$
0.50

Shares used in per share calculations:





 
 
 
 
Basic
262,881


265,942


267,780

 
266,299


266,068

Diluted
273,795


275,800


277,709

 
277,709


285,380






XILINX, INC.



CONDENSED CONSOLIDATED BALANCE SHEETS



(In thousands)




December 27, 2014

March 29,
2014 *
 
(unaudited)

 
ASSETS



Current assets:



  Cash, cash equivalents and short-term investments
$
2,920,768


$
2,457,321

  Accounts receivable, net
187,496


267,833

  Inventories
246,664


233,999

  Deferred tax assets and other current assets
160,213


107,994

Total current assets
3,515,141


3,067,147

Net property, plant and equipment
337,914


355,089

Long-term investments
654,013


1,190,775

Other assets
408,137


424,338

Total Assets
$
4,915,205


$
5,037,349









LIABILITIES , TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY



Current liabilities:



  Accounts payable and accrued liabilities
$
288,240


$
369,260

  Deferred income on shipments to distributors
51,486


55,099

  Current portion of long-term debt
573,290


565,001

Total current liabilities
913,016


989,360

Long-term debt
994,595


993,870

Deferred tax liabilities
293,138


253,433

Other long-term liabilities
14,268


13,005

Temporary equity
26,710


34,999

Stockholders' equity
2,673,478


2,752,682

Total Liabilities, Temporary Equity and Stockholders' Equity
$
4,915,205


$
5,037,349

 
 
 
 
 
 
 
 
* Derived from audited financial statements
 
 
 





XILINX, INC.





 
 
 
 
SUPPLEMENTAL FINANCIAL INFORMATION




 
 
 
 
(Unaudited)





 
 
 
 
(In thousands)





 
 
 
 

Three Months Ended
 
Nine Months Ended

December 27, 2014

September 27, 2014

December 28, 2013
 
December 27, 2014

December 28, 2013
SELECTED CASH FLOW INFORMATION:





 
 
 
 
  Depreciation
$
13,711


$
13,678


$
13,595

 
$
40,857


$
41,604

  Amortization
5,048


5,303


5,058

 
15,556


14,828

  Stock-based compensation
29,054


28,740


24,339

 
79,900


68,353

  Net cash provided by operating activities
290,742


203,881


216,390

 
624,741


615,542

  Purchases of property, plant and equipment
6,139


8,427


10,975

 
23,682


30,717

  Payment of dividends to stockholders
76,172


76,957


67,096

 
230,550


200,301

  Repurchases of common stock
174,997


199,999


97,140

 
476,012


167,121

  Proceeds from issuance of common stock
 
 
 
 
 
 





    to employees and excess tax benefit
16,700


2,452


12,729

 
36,007


157,611









 



STOCK-BASED COMPENSATION INCLUDED IN:







 



   Cost of revenues
$
2,339


$
2,077


$
1,966

 
$
6,408


$
5,628

   Research and development
14,909


14,831


11,912

 
40,245


33,474

   Selling, general and administrative
11,806


11,832


10,461

 
33,247


29,251